M&A: Page 8
-
Courtesy of Cardiovascular Systems Inc.
Abbott to pay $890M to acquire CSI, gaining atherectomy device
The deal expands Abbott’s vascular device lineup and access to additional products in development.
By Susan Kelly • Feb. 9, 2023 -
Globus agrees to buy NuVasive in stock deal valued at $3.1B, boosting spine business
The two firms expect their combined salesforce and shared operational strengths will better fend off competition.
By Elise Reuter • Updated Feb. 9, 2023 -
Zhanna Hapanovich via Getty Images
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.
By Nick Paul Taylor • Feb. 9, 2023 -
Gorodenkoff via Getty Images
Medtech trends in 2023Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.
By Peter Green • Jan. 31, 2023 -
simonkr via Getty Images
Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy
Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.
By Elise Reuter • Updated Jan. 18, 2023 -
Courtesy of Shockwave Medical
Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline
Neovasc already has a CE mark for the device and last year said it was targeting a 2025 approval by the FDA.
By Nick Paul Taylor • Jan. 18, 2023 -
Portra via Getty Images
‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts
The recovery of procedure volumes was “muted and uneven” in the fourth quarter with growth throttled by hospital staffing issues and worker absenteeism.
By Nick Paul Taylor • Jan. 13, 2023 -
Courtesy of Imactis
GE HealthCare to buy France’s IMACTIS in first acquisition as independent firm
IMACTIS’s CT-Navigation system is used to help surgeons in minimally invasive operations and reduce procedure time.
By Peter Green • Jan. 11, 2023 -
Permission granted by Medtronic
Medtronic CEO Martha: No more divestitures planned for 2023, but review continues
“The portfolio review is ongoing,” CEO Geoff Martha said, even as the world's largest medtech company plans to divest dialysis, respiratory interventions and patient monitoring businesses.
By Elise Reuter • Jan. 9, 2023 -
Tim Boyle via Getty Images
Baxter to spin off renal care, acute therapies units
The company is also considering the sale of its Biopharma Solutions business.
By Elise Reuter • Jan. 6, 2023 -
Courtesy of GE Healthcare
Q&AFriday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business.
By Peter Green • Jan. 6, 2023 -
Courtesy of Embody
Zimmer to acquire soft tissue repair firm Embody for as much as $275M
Buying Embody’s repair system for tendons and ligaments will expand Zimmer Biomet’s share in the growing sports medicine market.
By Elise Reuter • Jan. 5, 2023 -
ryasick via Getty Images
Deep DiveA look back at medtech’s top 10 acquisitions of 2022
While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.
By Elise Reuter • Dec. 22, 2022 -
Mario Tama via Getty Images
J&J closes acquisition of heart pump maker Abiomed
The $16.6 billion purchase was the largest medtech transaction of 2022.
By Elise Reuter • Dec. 22, 2022 -
Courtesy of Odin Vision
Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision
The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.
By Nick Paul Taylor • Dec. 21, 2022 -
Fujifilm agrees to buy Inspirata’s Dynamyx in challenge to Philips for digital pathology market
Fujifilm struck the deal after customers told it “digitizing pathology will be the most transformative thing they do for their practice.”
By Nick Paul Taylor • Dec. 21, 2022 -
Siemens, GE Healthcare are interested in Medtronic spinoff units: Bloomberg
Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.
By Elise Reuter • Dec. 15, 2022 -
Courtesy of Tandem Diabetes
Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market
The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.
By Nick Paul Taylor • Dec. 14, 2022 -
Courtesy of SD Biosensor
SD Biosensor postpones closing of $1.53B Meridian acquisition to complete financing
SD Biosensor, a company known in the West for its work with Roche, struck the deal to buy Meridian in July to expand into the U.S. in vitro diagnostic market.
By Nick Paul Taylor • Dec. 14, 2022 -
Courtesy of Boston Scientific
Boston Scientific pays $523M for control of Chinese device maker Acotec
The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.
By Peter Green • Dec. 12, 2022 -
Peter S Green/MedTech Dive
Q&AFriday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch
The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.
By Peter Green • Dec. 9, 2022 -
Carl Court via Getty Images
Cochlear’s $120M purchase of hearing-implant maker stirs European scrutiny
The European Commission said the merger “threatens to significantly affect competition in the market for cochlear implants and bone conduction solutions.”
By Nick Paul Taylor • Dec. 9, 2022 -
Courtesy of Indego
Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M
Indego and planned robotic assisted orthotic and prosthetic devices will slot into a portfolio of wearable robotics designed to tackle mobility loss.
By Nick Paul Taylor • Dec. 7, 2022 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Courtesy of Integra
Integra to buy Surgical Innovation Associates for $50M in bid to lead growing breast reconstruction niche
Human-derived surgical matrices dominate the market but Interga thinks synthetic and xenograft devices will gain ground.
By Nick Paul Taylor • Dec. 2, 2022
Previous
